ReviewFrontiers in oncology2021

Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets.

Jiangnan He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.